Gregory J. Riggins

3.5k total citations
35 papers, 1.9k citations indexed

About

Gregory J. Riggins is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gregory J. Riggins has authored 35 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gregory J. Riggins's work include Thyroid Cancer Diagnosis and Treatment (7 papers), BRCA gene mutations in cancer (4 papers) and Glioma Diagnosis and Treatment (4 papers). Gregory J. Riggins is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (7 papers), BRCA gene mutations in cancer (4 papers) and Glioma Diagnosis and Treatment (4 papers). Gregory J. Riggins collaborates with scholars based in United States, Brazil and Thailand. Gregory J. Riggins's co-authors include Verena Staedtke, Ren-Yuan Bai, Janete M. Cerutti, Gary L. Gallia, Ellen S. Pizer, Neil B. Rosenshein, Patrice J. Morin, Kathleen R. Cho, F.J. Montz and Colleen D. Hough and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Clinical Endocrinology & Metabolism and Cancer Cell.

In The Last Decade

Gregory J. Riggins

34 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gregory J. Riggins United States	21	1.0k	432	326	198	193	35	1.9k
Punit Saraon Canada	19	805 0.8×	236 0.5×	267 0.8×	92 0.5×	74 0.4×	25	1.5k
Mariana Salatino Argentina	24	1.5k 1.5×	871 2.0×	238 0.7×	117 0.6×	94 0.5×	43	2.7k
Geoffrey Bartholomeusz United States	24	2.0k 2.0×	1.1k 2.4×	482 1.5×	125 0.6×	161 0.8×	45	3.1k
Juha Klefström Finland	23	1.3k 1.3×	756 1.8×	423 1.3×	40 0.2×	254 1.3×	55	2.1k
Bingbing Dai United States	28	1.6k 1.5×	590 1.4×	470 1.4×	85 0.4×	342 1.8×	48	2.3k
Analisa DiFeo United States	31	2.2k 2.1×	448 1.0×	799 2.5×	52 0.3×	123 0.6×	74	2.9k
Ian Spendlove United Kingdom	32	1.3k 1.3×	983 2.3×	211 0.6×	353 1.8×	218 1.1×	74	3.3k
Douglas W. McMillin United States	25	1.2k 1.2×	837 1.9×	263 0.8×	114 0.6×	180 0.9×	57	2.1k
Alessandro Porrello United States	23	1.1k 1.0×	411 1.0×	258 0.8×	135 0.7×	89 0.5×	40	1.9k
Marialuisa Sensi Italy	27	1.4k 1.4×	1.1k 2.6×	287 0.9×	76 0.4×	145 0.8×	92	2.9k

Countries citing papers authored by Gregory J. Riggins

Since Specialization

Citations

This map shows the geographic impact of Gregory J. Riggins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory J. Riggins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory J. Riggins more than expected).

Fields of papers citing papers by Gregory J. Riggins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory J. Riggins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory J. Riggins. The network helps show where Gregory J. Riggins may publish in the future.

Co-authorship network of co-authors of Gregory J. Riggins

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory J. Riggins. A scholar is included among the top collaborators of Gregory J. Riggins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory J. Riggins. Gregory J. Riggins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Gerwen, Maaike van, Janete M. Cerutti, Thais Biude Mendes, et al.. (2023). TERT and BRAF V600E mutations in thyroid cancer of World Trade Center Responders. Carcinogenesis. 44(4). 350–355.

2.

Godet, Inês, et al.. (2022). Mebendazole prevents distant organ metastases in part by decreasing ITGβ4 expression and cancer stemness. Breast Cancer Research. 24(1). 98–98. 16 indexed citations

3.

Riggins, Gregory J., et al.. (2018). Mebendazole and radiation in combination increase survival through anticancer mechanisms in an intracranial rodent model of malignant meningioma. Journal of Neuro-Oncology. 140(3). 529–538. 34 indexed citations

4.

Bai, Ren-Yuan, et al.. (2016). Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model. Oncotarget. 7(42). 68571–68584. 62 indexed citations

5.

Bai, Ren-Yuan, Verena Staedtke, Michelle A. Rudek, et al.. (2015). Brain Penetration and Efficacy of Different Mebendazole Polymorphs in a Mouse Brain Tumor Model. Clinical Cancer Research. 21(15). 3462–3470. 70 indexed citations

6.

Sawanyawisuth, Kanlayanee, et al.. (2015). Suppression of trophoblast cell surface antigen 2 enhances proliferation and migration in liver fluke-associated cholangiocarcinoma. Annals of Hepatology. 15(1). 71–81. 24 indexed citations

7.

Bai, Ren-Yuan, Jon Chung, Alexandra Borodovsky, et al.. (2014). Repurposing the Antihelmintic Mebendazole as a Hedgehog Inhibitor. Molecular Cancer Therapeutics. 14(1). 3–13. 75 indexed citations

8.

Baía, Gilson S., Jessica Ho, Esteban Velarde, et al.. (2014). Preclinical evaluation of the combination of mTOR and proteasome inhibitors with radiotherapy in malignant peripheral nerve sheath tumors. Journal of Neuro-Oncology. 118(1). 83–92. 11 indexed citations

9.

Bai, Ren-Yuan, Verena Staedtke, Charles M. Rudin, Fred Bunz, & Gregory J. Riggins. (2014). Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis. Neuro-Oncology. 17(4). 545–554. 74 indexed citations

10.

Kim, James, Blake T. Aftab, Jean Y. Tang, et al.. (2013). Itraconazole and Arsenic Trioxide Inhibit Hedgehog Pathway Activation and Tumor Growth Associated with Acquired Resistance to Smoothened Antagonists. Cancer Cell. 23(1). 23–34. 271 indexed citations

11.

Sawanyawisuth, Kanlayanee, et al.. (2012). Characterizing Conflict in Wikipedia. PubMed. 45(6). 1264–70. 12 indexed citations

12.

Bai, Ren-Yuan, Verena Staedtke, Colette Aprhys, Gary L. Gallia, & Gregory J. Riggins. (2011). Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme. Neuro-Oncology. 13(9). 974–982. 157 indexed citations

13.

Cerutti, Janete M., Gisele Oler, Rosana Delcelo, et al.. (2010). PVALB, a New Hürthle Adenoma Diagnostic Marker Identified through Gene Expression. The Journal of Clinical Endocrinology & Metabolism. 96(1). E151–E160. 18 indexed citations

14.

Oler, Gisele, Cleber Camacho, Flávio Hojaij, et al.. (2008). Gene Expression Profiling of Papillary Thyroid Carcinoma Identifies Transcripts Correlated with BRAF Mutational Status and Lymph Node Metastasis. Clinical Cancer Research. 14(15). 4735–4742. 73 indexed citations

15.

Hemerly, Jefferson P., et al.. (2008). Re-expression of ABI3-binding protein suppresses thyroid tumor growth by promoting senescence and inhibiting invasion. Endocrine Related Cancer. 15(3). 787–799. 51 indexed citations

16.

Sawanyawisuth, Kanlayanee, Chaisiri Wongkham, Chawalit Pairojkul, et al.. (2006). Methionine aminopeptidase 2 over-expressed in cholangiocarcinoma: Potential for drug target. Acta Oncologica. 46(3). 378–385. 16 indexed citations

17.

Pérez‐Plasencia, Carlos, Gregory J. Riggins, Guelaguetza Vázquez-Ortíz, et al.. (2005). Characterization of the global profile of genes expressed in cervical epithelium by Serial Analysis of Gene Expression (SAGE). BMC Genomics. 6(1). 130–130. 15 indexed citations

18.

Cerutti, Janete M., Rosana Delcelo, Cláudia C. D. Nakabashi, et al.. (2004). A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. Journal of Clinical Investigation. 113(8). 1234–1242. 28 indexed citations

19.

Cerutti, Janete M., Rosana Delcelo, Cláudia C. D. Nakabashi, et al.. (2004). A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. Journal of Clinical Investigation. 113(8). 1234–1242. 153 indexed citations

20.

Riggins, Gregory J., et al.. (1992). CCG repeat polymorphism at the c-Ha-ras oncogene locus. Human Molecular Genetics. 1(9). 775–775. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact